Larite Industries Ltd.
BSE: 512325 | Sector: Health care |
NSE: N.A. | ISIN Code: N.A. |
BSE 05:30 | 01 Jan | Larite Industries Ltd |
NSE 05:30 | 01 Jan | Larite Industries Ltd |
Larite Industries Ltd. (LARITEINDS) - Market Capital
Market Cap
COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
Sun Pharma.Inds. | 587.25 | -2.77 | 627.95 | 315.20 | 140898.89 |
Divi's Lab. | 3600.40 | -1.16 | 3913.00 | 1632.70 | 95572.62 |
Dr Reddy's Labs | 5121.45 | -1.65 | 5514.65 | 2497.60 | 85169.72 |
Cipla | 812.35 | -1.36 | 869.65 | 356.75 | 65511.96 |
Aurobindo Pharma | 923.55 | -1.36 | 996.65 | 281.15 | 54110.79 |
Biocon | 449.55 | -1.58 | 487.70 | 235.80 | 53946.00 |
Lupin | 1085.05 | -0.74 | 1121.85 | 505.00 | 49207.02 |
Cadila Health. | 480.15 | -1.61 | 509.35 | 212.70 | 49152.96 |
Torrent Pharma. | 2676.60 | -1.35 | 3040.00 | 1619.00 | 45293.43 |
Gland Pharma | 2360.00 | -0.55 | 2509.05 | 1701.00 | 38538.80 |
Alkem Lab | 3042.95 | -1.93 | 3150.00 | 1950.00 | 36378.47 |
Apollo Hospitals | 2614.65 | 0.89 | 2631.00 | 1047.45 | 36375.01 |
Piramal Enterp. | 1606.00 | -1.14 | 1727.60 | 608.00 | 36223.33 |
Abbott India | 14800.00 | -1.32 | 18569.00 | 12218.10 | 31450.00 |
Ipca Labs. | 2132.00 | 0.98 | 2455.55 | 1162.00 | 27044.42 |
Glaxosmi. Pharma | 1526.80 | 0.72 | 1805.00 | 1046.40 | 25865.52 |
Syngene Intl. | 591.60 | -1.93 | 644.65 | 201.65 | 23664.00 |
Pfizer | 4978.05 | -2.65 | 5875.00 | 3588.15 | 22774.58 |
Alembic Pharma | 1075.00 | -1.19 | 1150.00 | 436.10 | 21129.13 |
Sanofi India | 8368.00 | 0.38 | 8999.00 | 5900.05 | 19271.50 |
Quick Links for Larite Industries:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices